---
title: GNS Healthcare Blog | John Reynders, Vice President Data Sciences, Alexion Pharmaceuticals
---

- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)

- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)

[![GNS](https://info.aitiabio.com/hubfs/GNS_Healthcare_October2018%20Theme/Images/gns_logo.png)](https://www.gnshealthcare.com/)

 

- Solutions 
    - [REFS Platform](https://www.gnshealthcare.com/refs-platform/)
    - [Subpopulations](https://www.gnshealthcare.com/subpopulations/)
    - [Value-based Drug Models](https://www.gnshealthcare.com/value-based-drug-models/)
    - [Intervention Optimization](https://www.gnshealthcare.com/intervention-optimization/)
    - [Customized Modeling](https://www.gnshealthcare.com/customized-modeling/)
- Who We Serve 
    - [Biopharma](https://www.gnshealthcare.com/biopharma/)
    - [Health Plans](https://www.gnshealthcare.com/health-plans/)
    - [Foundations](https://www.gnshealthcare.com/foundations/)
- Results 
    - [The Power of Causal Machine Learning](https://www.gnshealthcare.com/the-power-of-causal-machine-learning/)
    - [Journal Articles](https://www.gnshealthcare.com/journal-articles/)
    - [Posters](https://www.gnshealthcare.com/posters/)
- [News & Events](https://www.gnshealthcare.com/news/) 
    - [Blog](https://blog.gnshealthcare.com/)
    - [In the News](https://www.gnshealthcare.com/news/#news)
    - [Events](https://www.gnshealthcare.com/news/#events)
    - [Press Releases](https://www.gnshealthcare.com/news/#press-releases)
    - [GNS Precision Medicine Forum](https://www.gnshealthcare.com/gns-precision-medicine-forum/)
- About Us 
    - [Leadership](https://www.gnshealthcare.com/leadership/)
    - [Board of Directors](https://www.gnshealthcare.com/board-of-directors/)
    - [Strategic Advisory Board](https://www.gnshealthcare.com/strategic-advisory-board/)
    - [Our Culture](https://www.gnshealthcare.com/culture/)
    - [Careers](https://www.gnshealthcare.com/careers/)
    - [Contact](https://www.gnshealthcare.com/contact/)
- [Request Info](https://info.gnshealthcare.com/request-info-website)
- [Blog](https://blog.gnshealthcare.com/)
- [Careers](https://www.gnshealthcare.com/careers/)

## GNS Healthcare Blog

# GNS Healthcare Blog

## GNS Healthcare Primary Blog

 By <https://info.aitiabio.com/author/> December 31, 1969

Sep 13

[![RARE DISEASES-1](https://info.aitiabio.com/hubfs/RARE%20DISEASES-1.png)](https://info.aitiabio.com/how-ai-is-aiding-discoveries-in-rare-disease-research)

## [How AI is Aiding Discoveries in Rare Disease Research](https://info.aitiabio.com/how-ai-is-aiding-discoveries-in-rare-disease-research)

By [John Reynders, Vice President Data Sciences, Alexion Pharmaceuticals](https://info.aitiabio.com/author/john-reynders-vice-president-data-sciences-alexion-pharmaceuticals)  | [Big Data](https://info.aitiabio.com/topic/big-data), [Data Science](https://info.aitiabio.com/topic/data-science), [Drug Discovery](https://info.aitiabio.com/topic/drug-discovery), [Rare Disease](https://info.aitiabio.com/topic/rare-disease)

The Orphan Drug Act of 1983 defined a rare disease as one that affects less than 200,000 people. According to the NIH National Center for Advancing Translational Sciences, there are now 7,000 such diseases afflicting between 25-30 million people in the U. S. and an estimated 350 million worldwide.

Finding therapies for rare diseases not only helps those affected, but according to studies from the NIH Undiagnosed Diseases Program, new discoveries made from studying these diseases can also provide insights into more common conditions.

At Alexion, we are interested in understanding the rare...

[Read More](https://info.aitiabio.com/how-ai-is-aiding-discoveries-in-rare-disease-research)

### Subscribe to the GNS Newsletter

Search:

Search

### Follow Us:

<https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg?sub_confirmation=1><https://twitter.com/gnshealthcare><https://www.linkedin.com/company/1608800>

### Recent Posts:

### Categories:

- [AI (29)](https://info.aitiabio.com/topic/ai)
- [Precision Medicine (21)](https://info.aitiabio.com/topic/precision-medicine)
- [Artificial Intelligence (20)](https://info.aitiabio.com/topic/artificial-intelligence)
- [Machine Learning (20)](https://info.aitiabio.com/topic/machine-learning)
- [Future (13)](https://info.aitiabio.com/topic/future)
- [Big Data (12)](https://info.aitiabio.com/topic/big-data)
- [Healthcare (11)](https://info.aitiabio.com/topic/healthcare)

### Twitter

[Tweets by @gnshealthcare](https://twitter.com/gnshealthcare)

**About GNS Healthcare**  
 By leveraging the most powerful form of AI, called causal machine learning, we transform massive and diverse data streams to precisely match therapeutics, procedures, and care management interventions to individuals. We understand that in order to make precision medicine a reality, we need to discover and deliver insights that will cure disease and heal the healthcare system.

[Privacy Policy](https://www.gnshealthcare.com/privacy-policy)

![HITRUST](https://info.aitiabio.com/hubfs/GNS_Healthcare_October2018%20Theme/Images/HiTrust-Certified.jpg)

**Contact Us**  
 196 Broadway  
 Cambridge, MA 02139  
 Email: [info@gnshealthcare.com](mailto:info@gnshealthcare.com)  
 Phone: 617.374.2300

- [Twitter](https://twitter.com/gnshealthcare)
- [LinkedIn](https://www.linkedin.com/company/gns-healthcare/)
- [YouTube](https://www.youtube.com/channel/UC8RbKPCoi9Y-8BG_rEZEOXg)

© GNS Healthcare 561 Windsor St. A200, Somerville, MA 02143 | 617-374-2300